BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7556288)

  • 21. [Lymphocytic subpopulations in malignant ascites of ovarian origin. Flow cytometric analysis].
    De Leonardis A; Casamassima A; Chiuri E; Addabbo L; De Frenza N; Falco G
    Minerva Ginecol; 1993 Jun; 45(6):291-300. PubMed ID: 8355884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunophenotypic Dissection of Normal Peripheral Blood NK Associated (NKa) Subpopulations by Flow Cytometry: Morphological Features and Relationships Between Membrane NKa (CD11b, CD 16, CD56 and CD57) arid T-cell (CD2, CD3, TCR, CD5, CD7, CD8 and CD38) Associated Determinant Expression.
    Richards SJ; Scott CS
    Leuk Lymphoma; 1990; 2(1-2):111-26. PubMed ID: 27456578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.
    Nash MA; Lenzi R; Edwards CL; Kavanagh JJ; Kudelka AP; Verschraegen CF; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 1998 May; 112(2):172-80. PubMed ID: 9649178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic changes of T-lymphocyte subsets induced by interleukin-12 and interleukin-15 in umbilical cord vs. adult peripheral blood mononuclear cells.
    Lin SJ; Chao HC; Yan DC
    Pediatr Allergy Immunol; 2001 Feb; 12(1):21-6. PubMed ID: 11251861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
    Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
    J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinoma.
    Freedman RS; Gibbons JA; Giedlin M; Kudelka AP; Kavanagh JJ; Edwards CL; Carrasco CH; Nash MA; Platsoucas CD
    J Immunother Emphasis Tumor Immunol; 1996 Nov; 19(6):443-51. PubMed ID: 9041464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.
    Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M
    Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors.
    Baxevanis CN; Dedoussis GV; Gritzapis AD; Stathopoulos GP; Papamichail M
    Br J Cancer; 1994 Oct; 70(4):625-30. PubMed ID: 7917907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repopulation of circulating T, B and NK lymphocytes following bone marrow and blood stem cell transplantation.
    Parrado A; Casares S; Prieto J; Carmona M; Vaquero A; Rodríguez-Fernández JM
    Hematol Cell Ther; 1997 Dec; 39(6):301-6. PubMed ID: 9497889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic heterogeneity of persistent expansions of CD4+ CD8+ T cells.
    Tonutti E; Sala P; Feruglio C; Yin Z; Colombatti A
    Clin Immunol Immunopathol; 1994 Dec; 73(3):312-20. PubMed ID: 7955559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotype of lymphocyte in ovarian tumor peritoneal fluid. A preliminary study.
    Lacki J; Markowska J; Wiktorowicz K
    Eur J Gynaecol Oncol; 1992; 13(6):475-9. PubMed ID: 1473526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo CD3+CD25+ lymphocyte subpopulation is down-regulated without increased serum-soluble interleukin-2 receptor (sIL-2R) by gonadotropin releasing hormone agonist (GnRH-a).
    Ho HN; Wu MY; Chen HF; Chao KH; Yang YS; Huang SC; Lee TY; Gill TJ
    Am J Reprod Immunol; 1995 Jan; 33(1):134-9. PubMed ID: 7619228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the immune system of cancer patients by continuous i.v. recombinant IL-2 (rIL-2) therapy is dependent on dose and schedule of rIL-2.
    Gratama JW; Bruin RJ; Lamers CH; Oosterom R; Braakman E; Stoter G; Bolhuis RL
    Clin Exp Immunol; 1993 May; 92(2):185-93. PubMed ID: 8485906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Co-stimulation of multiple activating factors on proliferation and phenotype of T lymphocytes in peripheral blood in vitro].
    Liu JQ; Zhu Y; Chen FX; Zhang NZ; Lv XT; Zhou ZH; Zhang J; Zhang S; Tao ZZ; Li Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):367-70. PubMed ID: 22482405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
    Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
    Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer.
    Park HS; Kwon WS; Park S; Jo E; Lim SJ; Lee CK; Lee JB; Jung M; Kim HS; Beom SH; Park JY; Kim TS; Chung HC; Rha SY
    J Immunother Cancer; 2019 Oct; 7(1):268. PubMed ID: 31639056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of topotecan-based chemotherapy on the immune system of advanced ovarian cancer patients: an immunophenotypic study.
    Ferrari S; Rovati B; Cucca L; Scarabelli C; Presti M; Beccaria C; Collovà E; Porta C; Danova M
    Oncol Rep; 2002; 9(5):1107-13. PubMed ID: 12168081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective comparison of blood and peritoneal lymphocytes from continuous ambulatory peritoneal dialysis patients.
    Lewis SL; Bonner PN; Cooper CL; Holmes CJ
    J Clin Lab Immunol; 1992 Jan; 37(1):3-19. PubMed ID: 1339234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.